Price T Rowe Associates Inc Idexx Laboratories Inc Transaction History

Price T Rowe Associates Inc

  • $883 Billion
  • Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 536,101 shares of IDXX stock, worth $344 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
536,101
Previous 1,988,912 73.05%
Holding current value
$344 Million
Previous $835 Million 65.57%
% of portfolio
0.03%
Previous 0.1%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$361.04 - $536.34 $525 Million - $779 Million
-1,452,811 Reduced 73.05%
536,101 $288 Million
Q1 2025

May 14, 2025
BUY
$406.29 - $469.04 $336 Million - $387 Million
825,965 Added 71.02%
1,988,912 $835 Million
Q4 2024

Feb 14, 2025
SELL
$406.92 - $495.42 $152 Million - $185 Million
-373,905 Reduced 24.33%
1,162,947 $481 Million
Q3 2024

Nov 14, 2024
BUY
$455.08 - $517.19 $121 Million - $138 Million
265,970 Added 20.93%
1,536,852 $776 Million
Q2 2024

Aug 14, 2024
BUY
$468.04 - $548.53 $465 Million - $545 Million
993,366 Added 357.95%
1,270,882 $619 Million
Q1 2024

May 15, 2024
BUY
$515.08 - $576.87 $46,357 - $51,918
90 Added 0.03%
277,516 $150 Million
Q4 2023

Feb 14, 2024
BUY
$391.37 - $557.56 $6.46 Million - $9.2 Million
16,503 Added 6.32%
277,426 $154 Million
Q3 2023

Nov 14, 2023
BUY
$432.42 - $556.67 $22.9 Million - $29.4 Million
52,903 Added 25.43%
260,923 $114 Million
Q2 2023

Aug 14, 2023
BUY
$450.7 - $503.61 $15.4 Million - $17.2 Million
34,108 Added 19.61%
208,020 $104 Million
Q1 2023

May 15, 2023
SELL
$406.01 - $514.59 $61,307 - $77,703
-151 Reduced 0.09%
173,912 $87 Million
Q4 2022

Feb 14, 2023
SELL
$324.64 - $441.27 $7.07 Million - $9.61 Million
-21,779 Reduced 11.12%
174,063 $71 Million
Q3 2022

Nov 14, 2022
SELL
$325.8 - $407.78 $214 Million - $267 Million
-655,708 Reduced 77.0%
195,842 $63.8 Million
Q2 2022

Aug 15, 2022
SELL
$327.37 - $553.44 $71.3 Million - $120 Million
-217,711 Reduced 20.36%
851,550 $299 Million
Q1 2022

May 16, 2022
BUY
$466.52 - $631.01 $173 Million - $234 Million
370,413 Added 53.0%
1,069,261 $585 Million
Q4 2021

Feb 14, 2022
SELL
$586.54 - $666.48 $11.8 Million - $13.4 Million
-20,055 Reduced 2.79%
698,848 $460 Million
Q3 2021

Nov 15, 2021
SELL
$621.9 - $705.76 $8.02 Million - $9.1 Million
-12,888 Reduced 1.76%
718,903 $447 Million
Q2 2021

Aug 16, 2021
SELL
$486.36 - $637.08 $264 Million - $346 Million
-542,742 Reduced 42.58%
731,791 $462 Million
Q1 2021

May 17, 2021
SELL
$465.18 - $551.79 $343 Million - $407 Million
-737,860 Reduced 36.67%
1,274,533 $624 Million
Q4 2020

Feb 16, 2021
BUY
$383.85 - $499.87 $772 Million - $1.01 Billion
2,012,393 New
2,012,393 $1.01 Billion

Others Institutions Holding IDXX

# of Institutions
1,367
Shares Held
75.6M
Call Options Held
177K
Put Options Held
224K
View Full List

About IDEXX LABORATORIES INC

IDXX Quotes by TradingView
  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $53.4B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email